Alligator Bioscience AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
For the six months, sales was SEK 26.96 million compared to SEK 10.53 million a year ago. Revenue was SEK 29.09 million compared to SEK 10.99 million a year ago. Net loss was SEK 126.26 million compared to SEK 88.79 million a year ago. Basic loss per share from continuing operations was SEK 0.46 compared to SEK 0.4 a year ago. Diluted loss per share from continuing operations was SEK 0.46 compared to SEK 0.4 a year ago.